Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery
Source abstract
Abstract
Size scale plays an important role in the release properties and cellular presentation of drug delivery vehicles. Because negatively charged chondroitin sulfate (CS) is capable of electrostatically sequestering positively charged growth factors, CS-derived nanoscale micelles and microscale spheroids were synthesized as potential growth factor carriers to enhance differentiation of stem cells. Particles were characterized for morphology, size distribution, surface charge and cytocompatibility, as well as release of transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α). CS micelles were spherical and negatively charged with a bimodal distribution of 324.1±8.5 and 73.2±4.4 nm diameters, and CS microspheres possessed a rounded morphology and a diameter of 4.3±0.93 μm. Positively charged TGF-β1 demonstrated minimal release after loading in CS microspheres, while negatively charged TNF-α exhibited substantial release over the first 15 h, suggesting that TGF-β1 electrostatically complexed with CS. The micelles and microparticles were found to be cytocompatible at moderate concentrations with marrow stromal cell monolayers and within embryonic stem cell embryoid bodies. These synthesis techniques, which allow the formation of CS-based carriers over a variety of nano- and microscale sizes, offer versatility for tailored release of positively charged growth factors and controlled CS presentation for a variety of stem cell-based applications in tissue engineering and regenerative medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Proteoglycans and glycosaminoglycans research · Hydrogels: synthesis, properties, applications · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican10.1006/bbrc.1998.8759 ↗
2. Functions of heparan sulfate proteoglycans in cell signaling during development10.1242/dev.01522 ↗
3. Growth factors in the extracellular matrix10.1096/fasebj.11.1.9034166 ↗
4. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate–chitosan sponge for guided bone regeneration10.1016/S0168-3659(00)00232-7 ↗
5. Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate10.1002/jbm.a.32388 ↗
6. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles10.1016/S0168-3659(03)00328-6 ↗
7. Microparticles and nanoparticles for drug delivery10.1002/bit.21301 ↗
8. Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules10.1016/j.biomaterials.2009.01.007 ↗
9. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density10.1016/S0168-3659(00)00358-8 ↗
10. Preparation of amphiphilic poly(l-lactide)-graft-chondroitin sulfate copolymer self-aggregates and its aggregation behavior10.1021/bm050995j ↗
11. Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres10.1016/j.biomaterials.2007.01.049 ↗
12. Synthesis and characterizations of amphiphilic poly(l-lactide)-grafted chondroitin sulfate copolymer and its application as drug carrier10.1016/j.bioeng.2006.05.010 ↗
13. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks10.1016/S0142-9612(02)00420-9 ↗
14. Synthesis and characterization of photopolymerized multifunctional hydrogels: water-soluble poly(vinyl alcohol) and chondroitin sulfate macromers for chondrocyte encapsulation10.1021/ma0499324 ↗
15. A constrained regularization method for inverting data represented by linear algebraic or integral equations10.1016/0010-4655(82)90173-4 ↗
16. Contribution to the theory of electro-osmosis and related phenomena
17. Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation
18. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels10.1016/j.biomaterials.2006.10.006 ↗
19. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates10.1371/journal.pone.0001565 ↗
20. Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation10.1634/stemcells.2006-0523 ↗
21. Hydrogels for biomedical applications10.1016/S0169-409X(01)00239-3 ↗
22. Glycosaminoglycans and their binding to biological macromolecules10.1146/annurev.bi.47.070178.002125 ↗
23. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology10.1016/j.jconrel.2004.10.015 ↗
24. Controlled release of growth factors based on biodegradation of gelatin hydrogel10.1163/156856201744461 ↗
25. Human tumor necrosis factor. Production, purification, and characterization10.1016/S0021-9258(18)89560-6 ↗
26. Loading into and electro-stimulated release of peptides and proteins from chondroitin 4-sulphate hydrogels10.1016/S0928-0987(01)00193-2 ↗
27. Differential expression of TGF beta-1, beta-2 and beta-3 genes during mouse embryogenesis10.1242/dev.111.1.117 ↗
28. TGF beta 2 and TGF beta 3 have separate and sequential activities during epithelial–mesenchymal cell transformation in the embryonic heart10.1006/dbio.1999.9211 ↗
29. Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells
30. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity10.1016/0012-1606(91)90216-P ↗
31. In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta210.1016/S0040-8166(02)00106-4 ↗
32. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome10.1084/jem.169.1.333 ↗
33. How porosity and size affect the drug release mechanisms from PLGA-based microparticles10.1016/j.ijpharm.2005.07.031 ↗
34. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels10.1016/S0168-3659(03)00258-X ↗
35. Controlled immobilization of chondroitin sulfate in polyacrylic acid networks10.1163/156856207779146097 ↗
36. Preparation and properties of chitosan chondroitin sulfate complex microcapsules10.1016/j.colsurfb.2008.02.022 ↗
37. Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells10.1016/j.biomaterials.2007.05.039 ↗
38. Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint10.1002/1529-0131(199812)41:12<2185::AID-ART13>3.0.CO;2-C ↗
39. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo10.1016/S0021-9258(18)67049-8 ↗
40. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors10.1016/j.matbio.2006.10.012 ↗
41. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells10.1016/j.matbio.2007.07.002 ↗
42. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
43. Embryonic stem cell lines derived from human blastocysts10.1126/science.282.5391.1145 ↗
44. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to l-selectin, P-selectin, and CD4410.1074/jbc.M003387200 ↗
45. ASTM Standard F1903. Standard Practice for Testing for Biological Responses to Particles In Vitro. West Conshohocken, PA: ASTM International, 1998; 2003.
46. ASTM Standard F813. Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices. West Conshohocken, PA: ASTM International; 2007.